All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
REGN / Regeneron Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AKRX / Akorn, Inc.
|
|
|
|
|
|
|
|
US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
ISRG / Intuitive Surgical, Inc.
|
|
|
|
|
|
|
|
NPSP / NPS Pharmaceuticals Inc
|
|
|
|
|
|
|
|
RLYP / Relypsa, Inc.
|
|
|
|
|
|
|
|
XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
MDVN / Medivation, Inc.
|
|
|
|
|
|
|
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
KERX / Keryx Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
WX / Wuxi Pharmatech (Cayman) Inc.
|
|
|
|
|
|
|
|
G0083B108 / Actavis
|
|
|
|
|
|
|
|
PCYC / Pharmacyclics
|
|
|
|
|
|
|
|
US60877T1007 / Momenta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
INVA / Innoviva, Inc.
|
|
|
|
|
|
|
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GEVA / Synageva Biopharma Corp
|
|
|
|
|
|
|
|
PRGO / Perrigo Company plc
|
|
|
|
|
|
|
|
WMGIZ / Wright Medical Group N.V.
|
|
|
|
|
|
|
|
COV /
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
VIROPHARMA INC
/ (928241108) |
|
|
|
|
|
|
|
SHPG / Shire Plc.
|
|
|
|
|
|
|
|
OMED / OptMed Inc
|
|
|
|
|
|
|
|
HTWR / Heartware International Inc.
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
EVAC / EQV Ventures Acquisition Corp. II
|
|
|
|
|
|
|
|
CELG / Celgene Corp.
|
|
|
|
|
|
|
|
HOLX / Hologic, Inc.
|
|
|
|
|
|
|
|
NVS / Novartis AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
ALGN / Align Technology, Inc.
|
|
|
|
|
|
|
|
018490100 / Allergan plc
|
|
|
|
|
|
|
|
ARIA / ARIAD Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
0PP / Portola Pharmaceuticals Inc
|
|
|
|
|
|
|
|
TMO / Thermo Fisher Scientific Inc.
|
|
|
|
|
|
|
|
PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
US00C4U1L353 / Mylan N.V.
|
|
|
|
|
|
|
|
UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
PFE / Pfizer Inc.
|
|
|
|
|
|
|
|
SGEN / Seagen Inc
|
|
|
|
|
|
|
|
MNKKQ / Mallinckrodt Plc
|
|
|
|
|
|
|
|
SGNT / Sagent Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ARAY / Accuray Incorporated
|
|
|
|
|
|
|
|
DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
IONS / Ionis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BSX / Boston Scientific Corporation
|
|
|
|
|
|
|
|
HALO / Halozyme Therapeutics, Inc.
|
|
|
|
|
|
|
|
INCY / Incyte Corporation
|
|
|
|
|
|
|
|
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|